Vanguard Capital Management
LMAT icon

Vanguard Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Vanguard Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.5M Buy
953,437
+41,379
+5% +$4.24M ﹤0.01% 1595
2026
Q1 		$99.6M Buy
+912,058
New +$86.9M ﹤0.01% 1469

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Vanguard Capital Management's LMAT Position: Q2 2026 in Review

Vanguard Capital Management increased its LeMaitre Vascular (LMAT) stake by 4.5% in Q2 2026, buying an estimated $4.24M and bringing the position to 953,437 shares worth $91.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Vanguard Capital Management first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $99.6M in Q1 2026. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Vanguard Capital Management held 953,437 shares of LeMaitre Vascular worth $91.5M as of Q2 2026.
  • Vanguard Capital Management bought 41,379 LeMaitre Vascular shares in Q2 2026, an estimated $4.24M.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1595 holding.
  • Vanguard Capital Management first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's LeMaitre Vascular position peaked at $99.6M in Q1 2026.
  • 325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.